Please ensure Javascript is enabled for purposes of website accessibility

Why Align Technology, Insulet, and Intuitive Surgical Stocks Are Soaring Today

By Keith Speights - Mar 24, 2020 at 11:48AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors are optimistic about a potential federal stimulus bill.

What happened

Several medical device stocks are soaring today as investors anticipate that the U.S. Congress will pass a stimulus bill to boost the economy during the crisis caused by the coronavirus pandemic. Shares of Align Technology (ALGN -0.28%) were up 11% as of 11:38 a.m. EDT on Tuesday. Insulet (PODD -1.49%) stock was climbing 8.9% higher. Shares of Intuitive Surgical (ISRG -0.49%) were jumping 14.9%. 

So what

After political wrangling through the weekend and into early this week, lawmakers appear to be getting close to striking a deal, with Treasury Secretary Steve Mnuchin participating in some of the discussions. Both Democrats and Republicans involved in the negotiations over the stimulus package sounded confident that a bill that could pass both the House and the Senate would be agreed upon soon. The price tag of the bill is expected to be around $2 trillion.

Businessman holding palm out with lines trending up extending from a bright light above his palm

Image source: Getty Images.

What does this really mean for Align, Insulet, and Intuitive Surgical? It's uncertain that any of the three companies will be direct recipients of any stimulus to emerge from discussions on Capitol Hill.

However, hospitals could receive federal money, which could indirectly help Intuitive Surgical, which sells and leases robotic surgical systems to hospitals. It's also possible that money given directly to individuals could indirectly benefit Align, which sells clear dental aligners, and Insulet, which markets an insulin management system. Still, though, any financial impact for the companies is likely to be relatively small.

The main reason that these medical device stocks were jumping on Tuesday is that the potential of massive federal spending provides hope that the U.S. economy will bounce back sooner rather than later from the coronavirus pandemic. Investors are eager to have any reason for optimism, and the stimulus bill could provide one.

Now what

Today's big stock moves could prove to be only temporary euphoria. Expect high volatility for Align Technology, Insulet, Intuitive Surgical, and other healthcare stocks to continue for weeks and potentially even months. But decisive federal action could reduce the economic impact of the coronavirus outbreak. That would be good news for all stocks, even for companies that don't receive financial assistance themselves.

Keith Speights owns shares of Align Technology and Intuitive Surgical. The Motley Fool owns shares of and recommends Align Technology and Intuitive Surgical. The Motley Fool recommends Insulet. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Intuitive Surgical, Inc. Stock Quote
Intuitive Surgical, Inc.
ISRG
$239.13 (-0.49%) $-1.19
Align Technology, Inc. Stock Quote
Align Technology, Inc.
ALGN
$293.06 (-0.28%) $0.83
Insulet Corporation Stock Quote
Insulet Corporation
PODD
$263.06 (-1.49%) $-3.99

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
377%
 
S&P 500 Returns
123%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.